Prevalence of Anemia and Its Associated Factors in Antiretroviral-Treated HIVAIDS-Positive Adults from 2013 to 2018 at Debre Berhan Referral Hospital, Ethiopia

Joint Authors

Aynalem, Yared Asmare
Shibabaw Shiferaw, Wondimeneh
Woldiye, Zeleke

Source

Advances in Hematology

Issue

Vol. 2020, Issue 2020 (31 Dec. 2020), pp.1-7, 7 p.

Publisher

Hindawi Publishing Corporation

Publication Date

2020-03-11

Country of Publication

Egypt

No. of Pages

7

Main Subjects

Diseases
Medicine

Abstract EN

Introduction.

Anemia was defined as a hemoglobin level of less than or equal to 13.9 g/dl for male and less than or equal to 12.2 g/dl for female adults.

It is one of the most common hematological abnormalities in people living with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and is a determining factor for disease progression and death.

Among the countries in sub-Saharan Africa, Ethiopia is one of the most affected nations by HIV.

Therefore, this study aimed to assess the prevalence of anemia and its associated factors among HIV-positive adults that had received antiretroviral treatment (ART) at Debre Berhan Referral Hospital.

Methods.

An institution-based, descriptive, cross-sectional study was conducted involving 263 adults with HIV/AIDS that had undergone ART at Debre Berhan Referral Hospital, Ethiopia.

Data were collected from patient charts using systematic sampling with a pretested data extraction tool and entered using EpiData 3.1.

Variables having a p value ≤0.25 in the bivariate were fitted to a multivariable regression model with a 95% confidence interval.

p values ≤0.05 were considered statistically significant in the multivariate analysis.

Results.

Among the 263 HIV-positive patients, 237 (90.11%) were included in the final analysis.

The overall prevalence of anemia was 26.2%.

Factors that were significantly associated with anemia were past opportunistic infections, patients being in WHO clinical stage III and IV, and a BMI <18.5.

Conversely, those patients who took anti-TB medication were less likely to have anemia.

Conclusion.

Our study shows that the severity of anemia among HIV/AIDS patients that had undergone ART is lower than most studies conducted in Ethiopia.

We also found that opportunistic infection, WHO clinical staging, anti-TB treatment, and low BMI were significantly associated with anemia.

Therefore, routine screening of patient nutritional status and opportunistic infections may be useful in predicting and controlling anemia in HIV/AIDS patients.

American Psychological Association (APA)

Aynalem, Yared Asmare& Shibabaw Shiferaw, Wondimeneh& Woldiye, Zeleke. 2020. Prevalence of Anemia and Its Associated Factors in Antiretroviral-Treated HIVAIDS-Positive Adults from 2013 to 2018 at Debre Berhan Referral Hospital, Ethiopia. Advances in Hematology،Vol. 2020, no. 2020, pp.1-7.
https://search.emarefa.net/detail/BIM-1126417

Modern Language Association (MLA)

Aynalem, Yared Asmare…[et al.]. Prevalence of Anemia and Its Associated Factors in Antiretroviral-Treated HIVAIDS-Positive Adults from 2013 to 2018 at Debre Berhan Referral Hospital, Ethiopia. Advances in Hematology No. 2020 (2020), pp.1-7.
https://search.emarefa.net/detail/BIM-1126417

American Medical Association (AMA)

Aynalem, Yared Asmare& Shibabaw Shiferaw, Wondimeneh& Woldiye, Zeleke. Prevalence of Anemia and Its Associated Factors in Antiretroviral-Treated HIVAIDS-Positive Adults from 2013 to 2018 at Debre Berhan Referral Hospital, Ethiopia. Advances in Hematology. 2020. Vol. 2020, no. 2020, pp.1-7.
https://search.emarefa.net/detail/BIM-1126417

Data Type

Journal Articles

Language

English

Notes

Includes bibliographical references

Record ID

BIM-1126417